WILATE human coagulation factor VIII 900 IU and von Willebrand factor 800 IU powder for injection vial with diluent vial

Country: Australia

Bahasa: Inggeris

Sumber: Department of Health (Therapeutic Goods Administration)

Bahan aktif:

Von willebrand factor, Quantity: 800 IU; Factor VIII, Quantity: 900 IU; Factor VIII, Quantity: 15 mg

Boleh didapati daripada:

Octapharma Australia Pty Ltd

INN (Nama Antarabangsa):

Factor VIII,Von willebrand factor

Borang farmaseutikal:

Injection, powder for

Komposisi:

Excipient Ingredients: calcium chloride dihydrate; glycine; sodium chloride; sucrose; octoxinol 9; tributyl phosphate; sodium citrate dihydrate

Laluan pentadbiran:

Intravenous

Tanda-tanda terapeutik:

1. Von Willebrand disease (VWD): Treatment of bleeding episodes including surgical bleeding in patients with von Willebrand's disease when desmopressin treatment is ineffective or contraindicated. 2. Haemophilia A: Treatment and prophylaxis of bleeding including surgical bleeding in patients with haemophilia A (congenital FVIII deficiency). There are insuffcient data to recommend the use of Wilate in children less than 12 years of age.

Ringkasan produk:

Visual Identification: White or pale yellow or friable solid.;

Status kebenaran:

Licence status A

Tarikh kebenaran:

2007-09-26